Johnson & Johnson must pay $8 billion in punitive damages to a man who previousl...
FILE PHOTO: The Johnson and Johnson logo is seen at an office building in Singapore January 17, 2018. REUTERS/Thomas White
- Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday. The Philadelphia Court of Common Pleas jury’s verdict in favor of Nicholas Murray came in the first case in which a Pennsylvania jury had been able to consider awarding punitive damages in one of thousands of Risperdal cases pending in the state.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Johnson & Johnson Ordered To Pay $8 Million In Male Breast Growth CaseJ&J said it would appeal the decision.
Weiterlesen »
Jury says J&J must pay $8 billion in case over male breast growth linked to RisperdalJohnson & Johnson must pay $8 billion in punitive damages to a man who previousl...
Weiterlesen »
J&J Hit With $8 Billion Jury Award Over Antipsychotic DrugA Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a man who said his use of J&J’s antipsychotic Risperdal caused enlarged breasts.
Weiterlesen »
'I Wore $8 Press-Ons for A Month, And My Nails Have Never Been Healthier'I wore press-ons for one month straight, and my nails have never been healthier. These are my favorite picks.
Weiterlesen »
Jury says J&J must pay $8 billion in case over male breast growth linked to RisperdalJohnson & Johnson must pay $8 billion in punitive damages to a man who previousl...
Weiterlesen »
J&J Hit With $8 Billion Jury Award Over Antipsychotic DrugA Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a man who said his use of J&J’s antipsychotic Risperdal caused enlarged breasts.
Weiterlesen »